GDiseases, Disorders & Medical DisciplinesEIN: 900616879· Ruling Year: 2011

Coalition To Cure Calpain 3

Westport, Connecticut

CHealth Score
38C

Financial Health Score

8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.

Below Average

💰
$712K
Total Revenue
📊
$770K
Total Expenses
🏦
-$168K
Net Assets
📋
$420K
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
+73.6%
Year-over-year change (2022 → 2023)
Net Margin
-8.2%
Revenue minus expenses as % of revenue
Working Capital Ratio
-0.22
Net assets divided by total expenses
Liabilities-to-Assets
166.8%
Total liabilities as % of total assets

Filing History

13 filings on record
YearRevenueExpensesAssets
2023$711,92274%$770,45923%$252,04866%
2022$410,17313%$624,98074%$151,53645%
2021$469,23657%$358,7846%$275,34557%
2020$299,50950%$339,1742%$175,54916%
2019$599,91521%$345,95727%$210,054179%
2018$495,75163%$475,47749%$75,22361%
2017$303,43520%$319,474111%$193,3247%
2016$252,275290%$151,158459%$207,57495%
2015$64,7206%$27,03366%$106,29854%
2014$69,06081%$79,72976%$69,22713%
2013$355,29199%$330,58274%$79,76246%
2012$178,90684%$189,823495%$54,54717%
2011$97,226$31,920$65,446

Frequently Asked Questions

What does Coalition To Cure Calpain 3 do?

Coalition To Cure Calpain 3 is a diseases, disorders & medical disciplines nonprofit organization based in Connecticut. It is classified under NTEE code G125 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Coalition To Cure Calpain 3 financially healthy?

Financial health scoring requires Form 990 filing data. Check back as we process more filings for Coalition To Cure Calpain 3.

How much revenue does Coalition To Cure Calpain 3 generate?

Coalition To Cure Calpain 3 reports $646K in annual revenue and holds $217K in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Diseases, Disorders & Medical Disciplines category, or browse all nonprofits in Connecticut.